ebook img

Reviews of Physiology, Biochemistry and Pharmacology, Volume 99 PDF

229 Pages·1984·4.509 MB·English
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Reviews of Physiology, Biochemistry and Pharmacology, Volume 99

Reviews of 99 ,ygoloisyhP Biochemistry dna Pharmacology Editors R. H. Adrian, Cambridge • H. zur Hausen, Freiburg E. Helmreich, Wt~rzburg • H. Holzer, Freiburg R. Jung, Freiburg • R. J. Linden, Leeds P. A. Miescher, Gen~ve • J. Piiper, G6ttingen H. Rasmussen, New Haven. U. Trendelenburg, Wt~rzburg K. Ullrich, Frankfurt/M. • W. Vogt, G6ttingen A. Weber, Philadelphia htiW 63 serugiF Springer-Verlag Berlin Heidelberg NewYork Tokyo 1984 ISBN 3-540-12989-8 Springer-Verlag Berlin Heidelberg New York Tokyo ISBN 0-387-12989-8 Springer-Verlag New York Heidelberg Berlin Tokyo Library of Congress-Catalog-Card Number 74-3674 This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically those of translation, reprinting, re-use of illustra- tions, broadcasting, reproduction by photocopying machine or similar means, and stor- age in data banks. Under § 54 of the German Copyright Law where copies are made for other than private use, a fee is payable to 'Verwertungsgesellschaft Wort', Munich. © by Springer-VerlagB erlin Heidelberg 1984 Printed in Germany. The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant pro- tective laws and regulations and therefore free for general use. Product Liability: The publisher can give no guarantee for information about drug dosage and application thereof contained in this book. In every individual case the respective user must check its accuracy by consulting other pharmaceutical literature. Offsetprinting and Binding: Konrad Triltsch, Wtirzburg 2127/3130-543210 Contents Afferent Vagal C Fibre Innervation of the Lungs and Airways and Its Functional Significance. By J. C. G. EGDIRELOC and H. M. ,EGDIRELOC San Francisco, CA/USA. With 13 Figures Biology and Biochemistry of Papillomaviruses. By H. ,RETSIFP Erlangen/Federal Republic of Germany. With 5 Figures ....... lll Peritubular Capillary, Interstitium, and Lymph of the Renal Cortex. By G. G. ,RETNIP Baltimore, MD/USA, and K. ,RENTRAG Hannover/Federal Republic of Germany . . . . . . . . . . 381 Author Index . . . . . . . . . . . . . . . 203 Subject Index . . . . . . . . . . . . . . . . 223 dexednI ni tnerruC stnetnoC Rev, Physiol. Biochem, Pharmacol., Vol. 99 © by Springer-Verlag 1984 Afferent C Fibre Vagal Innervation of the Lungs and Airways and Its Functional Significance JOHN C.G, COLERIDGE and HAZEL M. COLERIDGE * Contents 1 Introduction ........................................... 2 Morphology ........................................... 4 Identification and Nomenclature of Lower Respiratory Tract C Fibres .... 9 3.1 Identification of C Fibres in Action Potential Studies .......... 9 3.2 Nomenclature of Lung and Airway C Fibres ................. 11 4 Afferent Properties of Lower Respiratory Tract C Fibres ............. 16 4.1 Response to Chemical Stimuli ......................... 16 4.1.1 Foreign Chemicals ................................. t7 4.1.2 Response to Lung Autocoids .......................... 21 4.1.2.1 Histamine ...................................... 22 4.1.2.2 Prostaglandins .................................... 24 4.1.2.3 Bradykinin ...................................... 26 4.1.3 Response to CO2 .................................. 27 4.2 Response to Changes in Lung Volume .................... 29 4.2.1 Response to Inflation ............................... 29 4.2.2 Response to Deflation .............................. 32 4.3 Response to Pulmonary Vascular Changes ................. 32 4.4 Pulmonary Embolism and Inflammation .................. 35 4.4.1 Pulmonary Embolism ............................... 35 4.4.2 Inflammation .................................... 36 5 Reflexes Triggered by Lower Respiratory Tract C Fibres .............. 36 5.1 Introduction to Reflexes Evoked by Chemicals ......... ..... 37 5.t .1 Nomenclature .................................... 37 5.1.2 Chemicals That Evoke Pulmonary Chemoreflexes ............ 38 5.1.3 Chemicals That Evoke Airway Defence Reflexes ............. 40 5.2 Introduction to Reflexes Evoked by Lung Inflation ........... 40 5.2.1 Head's Paradoxical Reflex in Rabbits .................... 40 5.2.2 Effects of Inflation in Other Species ..................... 42 5.3 Methods for Selective Vagal Block ...................... 44 5.3.1 Nerve Cooling .................................... 44 5.3.2 Anodal Polarization ................................ 45 5.3.3 Local Anaesthesia ................................. 46 5.4 Reflex Changes in Breathing .......................... 47 5.4.1 Effects of Stimulating Pulmonary C Fibres ................. 47 5.4.2 Effects of Stimulating Bronchial C Fibres .................. 51 5.5 Reflex Effects on Airway Smooth Muscle ................. 56 Cardiovascular Research Institute and Department o5 Physiology, University of California San Francisco, San Francisco, CA 94143, USA 2 J.C.G. Coleridge and H.M. Coleridge 5.5.1 Introduction ..................................... 56 5.5.2 Role of Pulmonary C Fibres .......................... 58 5.5.3 Role of Bronchial C Fibres ........................... 16 5.5.4 Role of C Fibres in Bronchomotor Tone .................. 64 5.6 Reflex Changes in Tracheobronchial Secretion .............. 65 5.6.I Effects of Pulmonary C Fibres on Secretion ................ 67 5.6.2 Effects of Bronchial C Fibres on Secretion ................. 67 5.7 Role of C Fibres in Cough and Irritant Sensations ............ 69 5.8 Reflex Cardiovascular Depressor Effects .................. 72 5.8.1 Role of Pulmonary C Fibres .......................... 72 5.8.1.1 Cardiac Effects ................................... 72 5.8.1.2 Effects on Peripheral Resistance ........................ 75 5.8.2 Role of Bronchial C Fibres ........................... 76 5.8.2.1 Cardiac Effects ................................... 76 5.8.2.2 Effects on Peripheral Resistance ........................ 77 5.9 Effects on Somatic Motor Function: the J Reflex ............ 77 6 Functional Significance ................................... 80 1.6 Physiological Role ................................. 18 6.1.1 Influence of Resting Discharge on Breathing Rate ............ 82 6.1.2 Afferent C Fibres and the Tachypnoea of the CO2 Response ..... 83 6.1.3 Role of Afferent C Fibres in Exercise .................... 85 6.2 Role in Airway Defence Reflexes ....................... 87 6.2.1 Afferent C Fibres and Inhaled Irritants ................... 87 6.2.2 Afferent C Fibres and Lung Autocoids ................... 89 6.2.3 Relative Roles of C Fibres and Irritant Receptors ............ 19 6.3 Role of C Fibres in Lung Disease ....................... 92 7 Conclusions ........................................... 96 References .............................................. 97 1 Introduction The first step towards identifying the impulse traffic in afferent vagal C fibres arising from the lungs and lower airways was taken in the early 1950s by Paintal (1955), who observed in cats that injection of phenyl- diguanide into the right atrium evoked low amplitude potentials in small multifibre bundles of the vagus nerve. Comparison of the effects of inject- ing phenyldiguanide upstream and downstream to the pulmonary vascular bed led Paintal to conclude that the impulses arose from the lung. The action potentials were of smaller amplitude than those recorded from any other afferent vagal fibre, and the conduction velocities of the fibres were thought to be less than 6 m s 1- . Subsequent observations by Paintal and others established that these fine fibres were non-myelinated and that they were widespread in the lungs and lower airways in several species (Paintal 1964, 1969; Coleridge et al. 1965, t968; Armstrong and Luck 1974; egdireloC and Coleridge 1977b; Russell and Trenchard 1980; Sapru et al. 1981). Fibres C and Airway Lung 3 Long before the impulse traffic in these afferent vagal C fibres was recorded, however, it was widely accepted that a 'fine fibre' afferent vagal input was responsible for initiating the powerfulPreflex effects observed when irritant gases were introduced into the lower trachea and when cer- tain chemicals were injected into the pulmonary circulation. The most telling observations were those on what came to be called the 'pulmonary chemoreflexes' (a decrease in heart rate and blood pressure, and apnoea followed by rapid shallow breathing) (reviewed by Dawes and Comroe 1954), which were clearly dependent on afferent vagal pathways, but which could still be evoked when the temperature of the vagus nerves was reduced to ° 3 or 4°C and conduction in all myelinated fibres eliminated. Moreover, there was evidence to suggest that noxious stimuli such as con- gestion, embolism and inflammation of the lung exerted at least a part of their reflex effects on breathing and heart rate by engaging this non- myelinated afferent pathway. Until recently, however, opinion has not generally favoured a reflex rote for afferent vagal C fibres under physiol- ogical conditions. This is somewhat surprising since more than 40 years ago Hammouda and Wilson (1939) presented evidence in dogs that small vagal fibres supplied a tonic input to the respiratory centres that increased breathing frequency and decreased tidal volume in the absence of any ab- normal stimulus. The lungs and airways, like the heart and great vessels, have a dual afferent innervation, with an input to the spinal cord as well as to the medulla. The spinal afferents travel in sympathetic nerve branches and are therefore called 'sympathetic afferents' (Kostreva et al. 1975). Sympa- thetic afferents of airway origin are capable of producing disturbances of breathing in response to irritant chemicals (Widdicombe 1954c; egdireloC et al. 1983), but unlike those that innervate the heart, they do not seem to be involved in the sensation of pain, which is transmitted instead by vagal afferents (Morton et al. 1951). We know less about sympa- thetic afferents from the lungs and airways than about those from the cardiovascular system, and nothing at all about afferent C fibres that may be a component of the former system. Hence our review deals only with the vagal C fibres. Various aspects of the afferent properties and functional role of vagal C fibres arising from the lower respiratory tract are discussed in a number of reviews (Dawes and Comroe 1954; Paintal 1963, 1964, 1973; Widdicombe 1964, 1974a, b, 1977a, 1981; egdireloC and egdireloC 1977c, 1979, 198t, to be published;Sant'Ambrogio 1982). In spite of the gradually accumulating weight of evidence that afferent C fibres from the lungs and airways play a significant role in the neural control of breathing, airway smooth muscle tone, airway secretion, heart rate and peripheral vascular resistance, a general impression persists of a somewhat mysterious afferent system, whose transducer properties are 4 Coleridge and H.M. Coleridge J.C.G. ill-defined and whose engagement by a variety of foreign chemicals pro- duces only stereotyped and primitive responses of a protective nature. Perhaps some of the reluctance to accept the hypothesis that non- myelinated afferents from the lower respiratory tract participate, like their myelinated counterparts, in regulatory reflexes of a more physiological nature stems from our general ignorance of the structure and appearance of the endings themselves. However, a similar lack of information about the appearance of sensory C fibre terminals in the skin regnuM( 1971) has not been an impediment to the general acceptance of the physiological importance of these cutaneous endings. What is known of the morphology of the C fibre innervation of the lungs and airways certainly deserves a place in this account. 2 Morphology Degeneration studies of the vagus nerve and its branches in cats reveal that of the 5000 or so afferent fibres distributed to the lungs and lower airways by each vagus nerve, about 4000 are non-myelinated (Agostoni et al. 1957). Nevertheless, the sensory terminals of these non-myelinated affer- ent fibres have been identified in reasonably large numbers only in the lungs and intrapulmonary airways of mice (Hung et al. 1972, 1973a, b). Information about the broad morphological features of this afferent vagal C fibre innervation, such as the light microscope has provided in the case of the myelinated afferents supplying the lower respiratory tract llesraL( 1921 ; nanrtflE 1943), is lacking - a deficit that at present shows little sign of being remedied. For instance, although present evidence suggests that the sensory terminals of non-myelinated fibres in the lung gnuH( et al. 1972, 1973a, b) have ultrastructural features in common with the termi- nals of myelinated fibres gniruD( et al. 1974), we do not know whether the non-myelinated fibres have terminal arborizations. Electron microscopists attempting to identify non-myelinated afferent fibres in the lower respiratory tract often confine their attention to the most distal divisions of the airways, probably in part because latniaP (1955, 1969) suggested that afferent C fibre endings are located in the alveolar walls close to the pulmonary capillaries, and in part because non- myelinated fibres in regions of the lung remote from the larger blood ves- sels and bronchi are thought less likely to be efferent. Using this selective sampling method, Meyrick and Reid 1971) found non-myelinated fibres in the alveolar walls in only 2 of 80 small blocks of lung tissue in 40 rats; one block contained a single profile of sensory appearance. (A sensory function is suggested by a terminal axonal enlargement, packed with Lung and Fibres Airway C 5 Fig. .1 Innervation of walls alveolar in the human Photomicrograph lung. (x 29100) of tissue taken from periphery of lung just beneath the pleural surface, showing nerve bundle in interstitium of alveolar wall. To left and above si air space contaminated by red cells. Two non-myelinated axons containing mitochondria, neurofilaments and are vesicles enveloped by Schwann cell cytoplasm and surrounded by collagen fibres. (Fox et al. 1980) mitochondria and only partly ensheathed by a Schwann cell covering, with close apposition between the axonal membrane and some adjacent cell.) In a study of human lung, Fox et al. (1980) took samples from the lung periphery immediately beneath the pleura and found non-myetinated fibres in the alveolar walls in 3 of 50 blocks taken from 16 lungs (Fig. 1) but were unable to identify sensory profiles. In studies on both rat and human lung, investigators were impressed by the scarcity of neural ele- ments in the alveolar wall, a finding very different from that in the mouse lung (see below). Fox et al. (1980) suggested that the scarcity of nerve fibres in their specimens might reflect a species variation. Such a scarcity may equally be a consequence of the restricted sampling methods, for afferent nerves may be scarce at the periphery of the lung. Hung et al. (1972, 1973) made a more extensive survey in the mouse and examined serial sections of the entire lung, including the hilar region. They found that non-myelinated fibres were regularly present in alveolar walls and alveolar ducts in all specimens examined. Indeed, several non- 6 J.C.G. Coleridge and H.M. Coleridge U 2N Fig. 2. Innervation of the pulmonary alveoli of the mouse lung. Above, electron micro- graph of an alveolar duct (x 1710). Arrows indicate two bundles of non-myelinated nerve fibres (NI~ ) N 2 in the interstitium surrounding an alveolar opening.Below, higher magnification (x 25 650) of the nerves NI and N2. Three non-myelinated axons can be seen on the left, and two on the right; the axons are partially or completely sur- rounded by Schwann cells (S) and contain many neurotubules and some mitochondria. CF, supporting collagenous fibrils. (Hung et al. 1972) myelinated fibres could be recognized in a single field at lower magnifica- tion and were followed through sequential serial sections, at higher magni- fications (Fig. 2), to axonal enlargements of a sensory type containing many mitochondria (Fig. 3) and usually associated with type I pneumo- cytes in the alveolar wall. The sensory enlargements were held to be the Lung and Airway C Fibres 7 Fig. 3. Innervation of the pulmonary alveoli of the mouse lung. Electron micrograph (x 25 200) showing an enlarged nerve ending (NE) in the wall of an alveolar duct [Alv). The ending, which contains numerous small mitochondria, has a bare surface facing the process of a type I pneumocyte (I) and separated from it by a basal lamina (BL). The opposite surface of the axon is capped by a Schwann cell sheath (S). A single non-myelinated axon (arrow) lies in the vicinity of the ending. ,I1 type II pneu- mocyte. (Hung et al. 1972) equivalent of Paintal's J receptors. Undoubtedly in these studies of mouse lung the investigators greatly increased their chances of finding the elusive non-myelinated fibres by carrying out a broad initial survey at low magni- fication. To make a comparable survey in human lungs, or even in the smaller lungs of dogs and cats, however, would be a daunting task.

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.